Currently, states are deciding how their short supply of monkeypox vaccines are being administered, and a few of the hardest-hit cities are launching pop-up monkeypox vaccination sites, but there isn’t a uniform task force yet.
Pharmacists have been inoculating people for decades, but the emergency declaration doesn’t automatically authorize the nation’s 60,000 pharmacy workers to administer the monkeypox vaccine. For that, the HHS would have to invoke the Public Readiness and Emergency Preparedness Act, which the ASHP urged the department to do in an Aug. 4 letter.
The HHS has a precedent for issuing the PREP Act during public health emergencies, as it’s currently in use for the COVID-19 pandemic, but the ASHP’s senior director of pharmacy practice and quality told Becker’s he thinks the HHS hasn’t enacted it yet because of vaccine supply issues.
“As the supply of vaccines expands, if there’s a need, we have an entire workforce available to help improve access,” Michael Ganio, PharmD, said.
Dr. Ganio said it’s unlikely the monkeypox outbreak will require mass immunization sites, which were used to vaccinate people during the height of the COVID-19 pandemic, but stressed the need to proactively employ pharmacists.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
